Figure 1: Identification of GSAP as an imatinib target. APP-CTF is cleaved by γ-secretase in the middle of its transmembrane domain to generate amyloid-β (γ-cleavage) and near its cytosolic membrane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback